“…Consequently, this would result in a change of concentration of other products both intermediate and final of the given signaling pathway such as cytokine, which would affect the concentration profile of irisin(Perakakis et al, 2017;Ye et al, 2019).The obtained results show that therapy with UDCA decreases the concentration of irisin. Simultaneously, it should be considered based on the data from literature, that the observed trend in the concentration changes of irisin during therapy indicates a growth in the expression of proinflammatory cytokines(Asghari et al, 2019;Eslampour et al, 2019). A second of the assessed indicators was chemerin, which for the most part is secreted by adipocytes of adipose tissue, hepatocytes, thrombocytes and nephrons.…”